FDA Import Refusal UPS-7478571-9/11/1 — Janssen Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc — FEI 2242843

The FDA refused shipment UPS-7478571-9/11/1 from Janssen Pharmaceuticals, Inc (United States) on Mar 9, 2018. The refused product falls under Drugs and Biologics — INFLIXIMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Mar 9, 2018
Country
United States
Product Category
Drugs and Biologics
Product Code
61YCP01 INFLIXIMAB
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.